Mertenil (Rosuvastatin)

Rosuvastatin works by inhibiting the enzyme HMG‑CoA reductase, a key step in the liver’s cholesterol synthesis pathway. This inhibition reduces the production of cholesterol, leading the liver to increase LDL‑receptor expression and clear more LDL particles from the bloodstream, thereby lowering blood cholesterol levels.

The appropriate dose of Mertenil is determined by the prescribing clinician based on the patient’s cholesterol levels, cardiovascular risk, age, and renal function. While common starting doses range from 5 mg to 10 mg once daily, the exact regimen is individualized and should follow the prescriber’s instructions.

Rosuvastatin is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because of potential fetal harm. It is also not recommended while breastfeeding, as it may pass into breast milk and affect the infant. Women of child‑bearing potential should use effective contraception while on therapy.

To order Mertenil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.

Rosuvastatin generally provides a more potent LDL‑cholesterol reduction at lower doses compared with many other statins such as atorvastatin or simvastatin. It also has a longer half‑life, allowing consistent lipid control with once‑daily dosing. However, individual response and tolerance vary, so clinicians choose the statin that best fits a patient’s risk profile and comorbidities.

Mertenil tablets should be stored at room temperature, below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Mertenil is taken orally as a tablet, usually once daily. The tablet can be swallowed whole with or without food. Patients should follow the dosing schedule prescribed by their healthcare provider and should not split, crush, or chew the tablet unless specifically instructed.

The most serious adverse reactions to watch for include rhabdomyolysis (severe muscle breakdown), significant liver enzyme elevations indicating hepatic injury, and rare but severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience unexplained muscle pain, dark urine, jaundice, or signs of a severe allergic response.

Mertenil should not be used by patients with active liver disease, unexplained persistent elevations of hepatic enzymes, or those who are pregnant or breastfeeding. It is also contraindicated in individuals with known hypersensitivity to rosuvastatin or any component of the formulation, and caution is advised in severe renal impairment.